How big is the Therapeutic Drug Monitoring Market?

The Therapeutic Drug Monitoring Market size is expected to reach USD 1.25 billion in 2024 and grow at a CAGR of 9.12% to reach USD 1.94 billion by 2029. Read More

What is the current Therapeutic Drug Monitoring Market size?

In 2024, the Therapeutic Drug Monitoring Market size is expected to reach USD 1.25 billion. Read More

Which is the fastest growing region in Therapeutic Drug Monitoring Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Therapeutic Drug Monitoring Market?

In 2024, the North America accounts for the largest market share in Therapeutic Drug Monitoring Market. Read More

What years does this Therapeutic Drug Monitoring Market cover, and what was the market size in 2023?

In 2023, the Therapeutic Drug Monitoring Market size was estimated at USD 1.15 billion. The report covers the Therapeutic Drug Monitoring Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Therapeutic Drug Monitoring Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Therapeutic Drug Monitoring Market Report | Industry Analysis, Size & Forecast

Therapeutic Drug Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Therapeutic Drug Monitoring Market is segmented by Technology (Immunoassays and Proteomic Technologies), Drug Class (Antiarrhythmic Drugs, Immunosuppressants, Antiepileptic Drugs, and Other Drug Classes), End-user (Hospitals, Diagnostic Centers, and Other End-users), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America).

Therapeutic Drug Monitoring Industry Overview

The therapeutic drug monitoring market is moderately competitive and consists of several major players. Some companies are expanding their market position by adopting various strategies, such as acquisitions and mergers, while others are developing new techniques for treating multiple disease indications and introducing new products to maintain their market share. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known, including F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Danaher Corporation (Beckman Coulter Inc.), and Siemens Healthcare GmbH, among others.